Drug Testing Experts
The Food and Drug Administration has granted orphan drug designation for a cannabis-based drug developed to treat childhood-onset epilepsy.
The Department of Transportation Notice of Proposed Rulemaking (NPRM) proposes to amend its drug-testing program regulation, 49 CFR part 40 (part 40), to add fentanyl (a
Beginning November 18, 2024, State Drivers License Agencies (SDLAs) across the nation will be required to remove the commercial driving privileges of drivers in a
As 2023 comes to an end there are major events occurring to increase the number of tools employers have available to test for Delta-9 THC,
Beginning November 18, 2024 drivers with a “prohibited” status in the clearinghouse will lose their state commercial driving privileges directly reported from the FMCSA Clearinghouse.